latest news releases from the newsroom
Seadrill: Sale of Shares in Apexindo
HAMILTON, Bermuda, Oct. 8, 2007 (PRIME NEWSWIRE) -- Seadrill has sold its entire holdings of 835,000,000 shares, representing an ownership share of approximately 32 percent, in the Indonesian drilling company PT Apexindo Pratma Duta Tbk for 2400 Indonesian rupiah (IDR) per share, equal to a total net consideration of approximately US$220 million. As a result of this sale, Seadrill is expected to record a gain of approximately US$150 million in the fourth quarter 2007.
MediciNova Will Announce Clinical Results From a Phase IIa Clinical Study for MN-221, a Novel Treatment for Status Asthmaticus, On Tuesday, October 9, 2007 At 3:00 a.m. Eastern Time
SAN DIEGO, Oct. 8, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), will announce results of a Phase IIa clinical study for MN-221, a novel treatment for status asthmaticus, at 3:00 A.M., Eastern time, tomorrow October 9th. Following the announcement, MediciNova will host a conference call to discuss the results at 10:00 A.M. Eastern time.